Key Metrics of Becton Dickinson
Revenue$19.4B▲ 2.7% YoYFY 2023
Operating income$2.1B▼ 7.5% YoY
Net profit$1.5B▼ 16.6% YoY
Shareholders' equity$25.3B
Market cap$54.6BBDX · $200.42
Competitors10identified
About Becton Dickinson
Sectors
Company details
- Website
- bd.com
- Registered office
- 202-204 Tolstoy House, Tolstoy Marg, New Delhi, In-dl, 110001
- Listed
- NYSE: BDX
Operational Areas of Becton Dickinson
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Entity details
CINU74899DL1995PTC064117
LEI code335800RVPTP9UJTYVY43
State codeDL
PIN code110001
Current legal nameBECTON DICKINSON
Classification—
Listing statusUnlisted
Registration no.064117
Company age—
PAN—
CountryUnited States
CityNew Delhi
StateDelhi
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—
Compliance
Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026
Industry classification
NIC code74899
Description of main activityOther business activities (consultancy, engineering, advertising, staffing)
Description of business activityOther business activities (consultancy, engineering, advertising, staffing)
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
US market & SEC filings
BDX · NYSE · SEC CIK 0000010795
Last price · 24 Oct 2026
$200.42
+3.13%
Market cap$54.6B
P/E40.6On FY 2023 diluted EPS
Volume1,383,262
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited States
BDX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
AGM for FY 2025-2630 Sep 2026
Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026
Statutory due date · 5 days left
MGT-7 for FY 2025-2629 Nov 2026
Statutory due date · 35 days left
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office202-204 TOLSTOY HOUSE, TOLSTOY MARG, NEW DELHI, IN-DL, 110001
GSTIN—
Email—
Websitehttp://www.bd.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Becton Dickinson
Competitors10identified
Locations1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | 10xgenomics.com | 2019 | United States |
Similar companies
C
Concord Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
D
Diabetology LtdPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
AbcodiaPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
E
ExelixisPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
G
Guardant HealthPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
N
Neurocrine BiosciencesPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
BioMarin PharmaceuticalPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Bio-Rad LaboratoriesPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
biotechnology
Filings
No filings on record yet.